Clinical

Dataset Information

Is it safe to add cediranib to weekly paclitaxel chemotherapy in women with ovarian cancer who are at risk of developing malignant bowel obstruction?


ABSTRACT: See https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-cediranib-for-women-with-ovarian-cancer-at-risk-of-having-a-bowel-obstruction-ceboc

DISEASE(S): Progressive,Platinum-resistant Ovarian Cancer,Platinum-resistant Or Refractory,High-grade Ovarian,Ovarian Cancer Recurrent,Neoplasms Benign, Malignant And Unspecified (incl Cysts And Polyps),Fallopian Tube Or Primary Peritoneal Cancer With High Risk Of Bowel Obstruction.

PROVIDER: 2416782 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets